Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income | ($14.1M) | ($32.4M) | ($49.3M) | ($46.7M) | ($52.8M) | ($45.8M) | ($45.3M) | ($44.8M) | ($55.7M) | ($28.9M) | ($21.5M) | ($57.1M) | ($63.9M) | ($42.5M) | ($186.3M) | $142.3M | $299.5M | $175.4M | $391.2M | $597.7M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, DexCom, Inc.'s last 12-month Operating Income is $628.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, DexCom, Inc.'s Operating Income growth was 18.9%. The average annual Operating Income growth rates for DexCom, Inc. have been 26.3% over the past three years, N/A over the past five years.
Over the last year, DexCom, Inc.'s Operating Income growth was 18.9%, which is higher than industry growth of (0.2%). It indicates that DexCom, Inc.'s Operating Income growth is Good.